Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Immunic, Inc. (IMUX)
USD14.85
+0.16 (+1.09%)
US NASDAQ Healthcare Biotechnology
Address
1200 Avenue of the Americas 10036
New York City, NY, US
New York City, NY, US
CEO
Daniel Vitt
Website
immunic-therapeutics.com
IPO
2014-04-17
CIK 1280776 ISIN US4525EP2001
Description
Immunic, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to pioneering selective oral immunotherapies for a range of chronic inflammatory and autoimmune conditions. Its primary investigational compound, IMU-838, has advanced to Phase 2 clinical trials, targeting relapsing-remitting multiple sclerosis (RRMS), inflammatory bowel disease (IBD), various other chronic inflammatory and autoimmune disorders, and also coronavirus disease. Additionally, the company is advancing IMU-935, which functions as an inverse agonist of RORγt, and IMU-856, designed to restore the intestinal barrier for patients afflicted with conditions like inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor-induced colitis, and other ailments affecting intestinal barrier integrity. The company's headquarters are located in New York, New York.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD14.85
+0.16 (+1.09%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
273.6K
Beta
1.39
Float Shares
9.56M
Free Float %
96.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.83% | +8.97% | +1.71% | +36.78% | +56.58% | +122.85% | +20.57% | -31.61% | -90.56% | -99.64% | -99.75% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (12 ratings, all time)
Buy
Price Targets & DCF
Current price
14.85
Low
2.50
-83.2%
Consensus
12.25
-17.5%
Median
12.25
-17.5%
High
22.00
+48.1%
DCF (Unlevered)
0.60
-96.0%
DCF (Levered)
0.95
-93.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 9 | 0 |
| Hold | 0 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 2 |
12.25
-17.5%
|
| Last Quarter | 2 |
12.25
-17.5%
|
| Last Year | 2 |
12.25
-17.5%
|
| All Time | 3 |
9.83
-33.8%
|
Quality scores
Altman Z-Score
-47.05
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+37.6% ★ Q1'26: +56.8% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+55.4% Q1'26: +197.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.01× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. 7 EPS Ana. |
Dec 2027 6 Rev. Ana. 6 EPS Ana. |
Dec 2028 8 Rev. Ana. 5 EPS Ana. |
Dec 2029 7 Rev. Ana. 1 EPS Ana. |
Dec 2030 7 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 12.0K (-100.0%)
|
—
est: 397.02M (-100.0%)
|
12.50M
541.7K – 24.46M
-96.9% YoY
|
1.00M
43.3K – 1.96M
-92.0% YoY
|
62.45M
2.71M – 122.19M
+6,144.8% YoY
|
252.80M
10.96M – 494.65M
+304.8% YoY
|
477.64M
20.70M – 934.57M
+88.9% YoY
|
| EBITDA |
-97.92M
|
-97.00M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-98.05M
|
-97.17M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-100.51M
est: -149.95M (+33.0%)
|
-97.17M
est: -97.17M (+0.0%)
|
-63.71M
-94.82M – -32.60M
+34.4% YoY
|
-55.29M
-79.12M – -31.46M
+13.2% YoY
|
-55.27M
-70.06M – -40.48M
+0.0% YoY
|
14.95M
-3.64M – 33.53M
+127.0% YoY
|
86.10M
-20.98M – 193.17M
+476.0% YoY
|
| SGA |
18.01M
|
21.25M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-10.00
est: -9.58 (-4.3%)
|
-6.24
est: -6.31 (+1.1%)
|
-3.27
-6.09 – -2.09
+48.1% YoY
|
-3.13
-5.08 – -2.02
+4.4% YoY
|
-3.29
-4.50 – -2.60
-5.2% YoY
|
0.96
-0.23 – 2.15
+129.2% YoY
|
5.53
-1.35 – 12.41
+476.0% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-30 | HC Wainwright & Co. | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-65.14M
OE per share TTM
-21.76
Owner's Yield
-34.87%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
160,440.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
21
Total invested
17.35M
Insider transactions (90d)
1
Beneficial owners (>5%)
39
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BVF Inc. | 8.90M | 9.90% | — | — | — | 8.90M | CO | Delaware | 2024-01-18 | ↗ |
| 2 | BVF Partners L.P. | 8.90M | 9.90% | — | — | — | 8.90M | IA, PN | Delaware | 2024-01-18 | ↗ |
| 3 | Mark N. Lampert | 8.90M | 9.90% | — | — | — | 8.90M | IN | Delaware | 2024-01-18 | ↗ |
| 4 | ( | 8.90M | 9.90% | — | 8.90M | — | — | IA, PN | Delaware | 2024-01-16 | ↗ |
| 5 | BVF GP Holdings LLC | 8.31M | 9.20% | — | — | — | 8.31M | OO | Delaware | 2024-01-18 | ↗ |
| 6 | Guy Levy | 7.29M | 8.10% | — | 7.29M | — | 7.29M | IN | United States | 2024-01-10 | ↗ |
| 7 | EIN #00-0000000 | 6.69M | 7.40% | — | 6.69M | — | 6.69M | OO | Jersey, Channel Islands | 2024-01-18 | ↗ |
| 8 | Adage Capital Management, L.P. | 5.59M | 6.21% | — | 5.59M | — | — | IA, PN | Delaware | 2024-11-12 | ↗ |
| 9 | Phillip Gross | 5.59M | 6.21% | — | 5.59M | — | — | HC, IN | United States | 2024-11-12 | ↗ |
| 10 | Robert Atchinson | 5.59M | 6.21% | — | 5.59M | — | — | HC, IN | United States | 2024-11-12 | ↗ |
| 11 | Soleus PE GP III, LLC | 4.90M | 5.40% | — | 4.90M | — | 4.90M | OO | Delaware | 2024-01-10 | ↗ |
| 12 | Soleus Private Equity Fund III, L.P. | 4.90M | 5.40% | — | 4.90M | — | 4.90M | PN | Delaware | 2024-01-10 | ↗ |
| 13 | Soleus Private Equity GP III, LLC | 4.90M | 5.40% | — | 4.90M | — | 4.90M | OO | Delaware | 2024-01-10 | ↗ |
| 14 | BVF I GP LLC | 4.67M | 5.20% | — | — | — | 4.67M | OO | Delaware | 2024-01-18 | ↗ |
| 15 | Biotechnology Value Fund, L.P. | 4.67M | 5.20% | — | — | — | 4.67M | PN | Delaware | 2024-01-18 | ↗ |
| 16 | David Kroin | 4.02M | 9.29% | — | 4.02M | — | — | HC, IN | United States | 2022-10-20 | ↗ |
| 17 | Deep Track Biotechnology Master Fund, Ltd. | 4.02M | 9.29% | — | 4.02M | — | — | CO | Cayman Islands | 2022-10-20 | ↗ |
| 18 | Deep Track Capital, LP | 4.02M | 9.29% | — | 4.02M | — | — | IA, OO | Delaware | 2022-10-20 | ↗ |
| 19 | Capital LP | 3.77M | 9.30% | — | 3.77M | — | 3.77M | IA | USA | 2022-10-21 | ↗ |
| 20 | Capital Master LP | 3.77M | 9.30% | — | 3.77M | — | 3.77M | OO | Cayman Islands | 2022-10-21 | ↗ |
| 21 | BVF II GP LLC | 3.65M | 4.10% | — | — | — | 3.65M | OO | Delaware | 2024-01-18 | ↗ |
| 22 | Biotechnology Value Fund II, L.P. | 3.65M | 4.10% | — | — | — | 3.65M | PN | Delaware | 2024-01-18 | ↗ |
| 23 | Soleus Capital Group, LLC | 2.40M | 2.70% | — | 2.40M | — | 2.40M | OO | Delaware | 2024-01-10 | ↗ |
| 24 | Soleus Capital Master Fund, L.P. | 2.40M | 2.70% | — | 2.40M | — | 2.40M | FI | Cayman Islands | 2024-01-10 | ↗ |
| 25 | Soleus Capital, LLC | 2.40M | 2.70% | — | 2.40M | — | 2.40M | OO | Delaware | 2024-01-10 | ↗ |
| 26 | ROI Verwaltungsgesellschaft mbH | 1.97M | 5.00% | 1.97M | — | 1.97M | — | CO | Federal Republic of Germany | 2022-11-25 | ↗ |
| 27 | Roland Oetker | 1.97M | 5.00% | 1.97M | — | 1.97M | — | IN | Federal Republic of Germany | 2022-11-25 | ↗ |
| 28 | Suzanne Madeleine Oetker-von Franquet | 1.97M | 5.00% | 1.97M | — | 1.97M | — | IN | Federal Republic of Germany | 2022-11-28 | ↗ |
| 29 | Steven A. Cohen | 1.92M | 4.00% | — | 1.92M | — | 1.92M | IN | Delaware | 2022-10-24 | ↗ |
| 30 | Point72 Asset Management, L.P. | 1.91M | 4.00% | — | 1.91M | — | 1.91M | PN | Delaware | 2022-10-24 | ↗ |
| 31 | Point72 Capital Advisors, Inc. | 1.91M | 4.00% | — | 1.91M | — | 1.91M | CO | Delaware | 2022-10-24 | ↗ |
| 32 | RTW Investments, LP | 1.72M | 6.50% | — | 1.72M | — | — | IA, PN | Delaware | 2022-02-14 | ↗ |
| 33 | Roderick Wong | 1.72M | 6.50% | — | 1.72M | — | — | HC, IN | United States | 2022-02-14 | ↗ |
| 34 | 1,064,578 shares of common stock * | 1.06M | 5.10% | 1.06M | — | — | — | IN | Federal Republic of Germany | 2021-02-19 | ↗ |
| 35 | 13G | 700.0K | 3.40% | 700.0K | — | 700.0K | — | OO | Bermuda | 2021-02-16 | ↗ |
| 36 | BVF Partners OS Ltd. | 461.2K | 1.00% | — | — | — | 461.2K | CO | Delaware | 2024-01-18 | ↗ |
| 37 | Biotechnology Value Trading Fund OS LP | 461.2K | 1.00% | — | — | — | 461.2K | PN | Delaware | 2024-01-18 | ↗ |
| 38 | Altium Growth GP, LLC | 244.2K | 1.20% | — | 244.2K | — | — | OO | Delaware, United States of America | 2021-02-12 | ↗ |
| 39 | Cubist Systematic Strategies, LLC | 5.6K | 4.00% | — | 5.6K | — | 5.6K | OO | Delaware | 2022-10-24 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
21
-42 vs prev Q
New positions
9
Closed positions
48
Increased
13
Reduced
2
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ABRDN PLC | 8.24M +— (+0.0%) | 4.40M -2.9M (-39.5%) | 4.25% -1.985 pp | 0.01% -0.005 pp | USD0.75 -29.3% | 4 qtrs — |
| 2 | BVF INC/IL | 7.65M +— (+0.0%) | 4.08M -2.7M (-39.5%) | 3.95% -1.843 pp | 0.14% -0.136 pp | USD1.36 -61.0% | 13 qtrs — |
| 3 | VANGUARD GROUP INC | 5.02M +675.2K (+15.5%) | 2.68M -1.2M (-30.0%) | 2.59% -0.698 pp | 0.00% +0.000 pp | USD3.20 -83.4% | 27 qtrs — |
| 4 | AVIDITY PARTNERS MANAGEMENT LP | 4.70M +— (+0.0%) | 2.51M -1.6M (-39.5%) | 2.42% -1.132 pp | 0.72% -0.220 pp | USD1.22 -56.6% | 8 qtrs — |
| 5 | NANTAHALA CAPITAL MANAGEMENT, LLC | 4.38M +4.4M (+100.0%) | 2.34M +2.3M (+100.0%) | 2.26% +2.258 pp | 0.08% +0.077 pp | USD0.53 +0.0% | 1 qtrs NEW |
| 6 | COLONY GROUP, LLC | 2.62M +40.9K (+1.6%) | 2.29M +15.9K (+0.7%) | 1.35% -0.601 pp | 0.00% -0.001 pp | USD1.53 -65.4% | 6 qtrs — |
| 7 | LAURION CAPITAL MANAGEMENT LP | 3.88M +2.0M (+106.3%) | 2.07M +412.6K (+24.9%) | 2.00% +0.578 pp | 0.08% +0.049 pp | USD0.64 -17.2% | 4 qtrs — |
| 8 | MILLENNIUM MANAGEMENT LLC | 3.42M +2.9M (+544.6%) | 1.82M +1.4M (+290.2%) | 1.76% +1.362 pp | 0.00% +0.001 pp | USD0.59 -10.2% | 27 qtrs — |
| 9 | MORGAN STANLEY | 2.09M -1.0M (-32.6%) | 1.12M -1.6M (-59.2%) | 1.08% -1.269 pp | 0.00% 0.000 pp | USD0.78 -32.1% | 27 qtrs — |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.40M +— (+0.0%) | 746.4K -486.6K (-39.5%) | 0.72% -0.337 pp | 0.00% -0.001 pp | USD1.36 -61.0% | 8 qtrs — |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 1.18M +142.5K (+13.8%) | 627.9K -283.7K (-31.1%) | 0.61% -0.176 pp | 0.00% +0.000 pp | USD3.37 -84.3% | 23 qtrs — |
| 12 | MARSHALL WACE, LLP | 1.02M +486.5K (+91.2%) | 540.6K +71.1K (+15.1%) | 0.53% +0.122 pp | 0.00% +0.000 pp | USD0.75 -29.3% | 14 qtrs — |
| 13 | BLACKROCK, INC. | 717.5K -8.3K (-1.1%) | 382.9K -256.9K (-40.2%) | 0.37% -0.179 pp | 0.00% +0.000 pp | USD1.54 -65.6% | 6 qtrs — |
| 14 | IKARIAN CAPITAL, LLC | 674.7K -239.5K (-26.2%) | 360.1K -445.9K (-55.3%) | 0.35% -0.344 pp | 0.03% -0.053 pp | USD1.11 -52.3% | 15 qtrs — |
| 15 | UBS GROUP AG | 537.1K +498.4K (+1,288.4%) | 286.8K +252.7K (+740.6%) | 0.28% +0.248 pp | 0.00% +0.000 pp | USD0.56 -5.4% | 19 qtrs — |
| 16 | GSA CAPITAL PARTNERS LLP | 527.5K +334.5K (+173.4%) | 282.0K +112.0K (+65.9%) | 0.27% +0.126 pp | 0.02% +0.010 pp | USD0.66 -19.7% | 7 qtrs — |
| 17 | SQUAREPOINT OPS LLC | 352.9K +81.3K (+29.9%) | 188.3K -51.1K (-21.3%) | 0.18% -0.024 pp | 0.00% +0.000 pp | USD0.80 -33.8% | 2 qtrs — |
| 18 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 333.8K +333.8K (+100.0%) | 178.2K +178.2K (+100.0%) | 0.17% +0.172 pp | 0.00% +0.000 pp | USD0.53 +0.0% | 1 qtrs NEW |
| 19 | STATE STREET CORP | 331.9K +— (+0.0%) | 177.2K -115.5K (-39.5%) | 0.17% -0.080 pp | 0.00% +0.000 pp | USD3.55 -85.1% | 23 qtrs — |
| 20 | CONNECTIVE CAPITAL MANAGEMENT, LLC | 301.3K +301.3K (+100.0%) | 160.8K +160.8K (+100.0%) | 0.16% +0.155 pp | 0.09% +0.095 pp | USD0.53 +0.0% | 1 qtrs NEW |
| 21 | JANE STREET GROUP, LLC | 286.7K +91.3K (+46.8%) | 153.0K -19.2K (-11.2%) | 0.15% +0.000 pp | 0.00% +0.000 pp | USD0.77 -31.2% | 8 qtrs — |
| 22 | CITADEL ADVISORS LLC | 266.8K -268.3K (-50.1%) | 142.4K -329.3K (-69.8%) | 0.14% -0.267 pp | 0.00% 0.000 pp | USD0.88 -39.8% | 2 qtrs — |
| 23 | XTX TOPCO LTD | 225.3K +225.3K (+100.0%) | 120.2K +120.2K (+100.0%) | 0.12% +0.116 pp | 0.00% +0.003 pp | USD0.53 +0.0% | 1 qtrs NEW |
| 24 | NORTHERN TRUST CORP | 220.7K +9.4K (+4.4%) | 117.8K -68.5K (-36.8%) | 0.11% -0.046 pp | 0.00% +0.000 pp | USD4.19 -87.4% | 23 qtrs — |
| 25 | — | 155.2K +155.2K (+100.0%) | 82.8K +82.8K (+100.0%) | 0.08% +0.080 pp | 0.06% +0.063 pp | USD0.53 +0.0% | 1 qtrs NEW |
| 26 | BOOTHBAY FUND MANAGEMENT, LLC | 130.6K -110.3K (-45.8%) | 69.7K -142.7K (-67.2%) | 0.07% -0.115 pp | 0.00% -0.002 pp | USD1.37 -61.3% | 15 qtrs — |
| 27 | STRATEGIES WEALTH ADVISORS, LLC | 100.0K +— (+0.0%) | 53.4K -34.8K (-39.5%) | 0.05% -0.024 pp | 0.01% -0.004 pp | USD0.70 -24.3% | 3 qtrs — |
| 28 | HB WEALTH MANAGEMENT, LLC | 91.5K +— (+0.0%) | 48.8K -31.8K (-39.5%) | 0.05% -0.022 pp | 0.00% 0.000 pp | USD0.88 -39.8% | 5 qtrs — |
| 29 | TWO SIGMA INVESTMENTS, LP | 76.2K +17.5K (+29.8%) | 40.7K -11.1K (-21.4%) | 0.04% -0.005 pp | 0.00% +0.000 pp | USD0.80 -33.8% | 2 qtrs — |
| 30 | LPL FINANCIAL LLC | 58.1K +5.0K (+9.4%) | 31.0K -15.8K (-33.8%) | 0.03% -0.010 pp | 0.00% +0.000 pp | USD0.85 -37.6% | 2 qtrs — |
| 31 | CAPTION MANAGEMENT, LLC | 50.0K +— (+0.0%) | 26.7K -17.4K (-39.5%) | 0.03% -0.012 pp | 0.00% 0.000 pp | USD0.88 -39.8% | 2 qtrs — |
| 32 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 40.0K -75.0K (-65.2%) | 21.3K -80.0K (-78.9%) | 0.02% -0.066 pp | 0.00% -0.002 pp | USD2.27 -76.7% | 18 qtrs — |
| 33 | CREATIVE PLANNING | 35.0K +— (+0.0%) | 18.7K -12.2K (-39.5%) | 0.02% -0.008 pp | 0.00% +0.000 pp | USD1.00 -47.0% | 5 qtrs — |
| 34 | MAREX GROUP PLC | 32.7K +10.2K (+45.3%) | 17.5K -2.4K (-12.0%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD0.65 -18.5% | 3 qtrs — |
| 35 | BANK OF NEW YORK MELLON CORP | 30.5K +— (+0.0%) | 16.3K -10.6K (-39.5%) | 0.02% -0.007 pp | 0.00% +0.000 pp | USD12.56 -95.8% | 22 qtrs — |
| 36 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 25.0K +— (+0.0%) | 13.3K -8.7K (-39.5%) | 0.01% -0.006 pp | 0.00% +0.000 pp | USD1.49 -64.4% | 12 qtrs — |
| 37 | STONEX GROUP INC. | 20.5K +20.5K (+100.0%) | 11.0K +11.0K (+100.0%) | 0.01% +0.011 pp | 0.00% +0.001 pp | USD0.53 +0.0% | 1 qtrs NEW |
| 38 | BALBOA WEALTH PARTNERS | 12.0K +— (+0.0%) | 6.4K -4.2K (-39.5%) | 0.01% -0.003 pp | 0.00% -0.001 pp | USD1.65 -67.9% | 11 qtrs — |
| 39 | LEVEL FOUR ADVISORY SERVICES, LLC | 10.8K +— (+0.0%) | 5.8K -3.8K (-39.5%) | 0.01% -0.003 pp | 0.00% 0.000 pp | USD1.49 -64.4% | 12 qtrs — |
| 40 | PFG INVESTMENTS, LLC | 10.5K +— (+0.0%) | 5.6K -3.7K (-39.5%) | 0.01% -0.003 pp | 0.00% 0.000 pp | USD1.65 -67.9% | 6 qtrs — |
| 41 | RETIREMENT PLANNING GROUP | 10.4K +— (+0.0%) | 5.6K -3.6K (-39.5%) | 0.01% -0.003 pp | 0.00% 0.000 pp | USD1.09 -51.4% | 4 qtrs — |
| 42 | PRIVATE ADVISOR GROUP, LLC | 10.0K +— (+0.0%) | 5.3K -3.5K (-39.5%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD1.50 -64.7% | 9 qtrs — |
| 43 | CRESCENT GROVE ADVISORS, LLC | 10.0K +— (+0.0%) | 5.3K -3.5K (-39.5%) | 0.01% -0.002 pp | 0.00% 0.000 pp | USD1.09 -51.4% | 4 qtrs — |
| 44 | DYNAMIC ADVISOR SOLUTIONS LLC | 10.0K +— (+0.0%) | 5.3K -3.5K (-39.5%) | 0.01% -0.002 pp | 0.00% 0.000 pp | USD1.09 -51.4% | 4 qtrs — |
| 45 | CWM, LLC | 8.6K +— (+0.0%) | 5.0K -3.0K (-37.5%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD1.00 -47.0% | 5 qtrs — |
| 46 | ADDISON ADVISORS LLC | 5.2K +— (+0.0%) | 2.8K -1.8K (-39.5%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD1.00 -47.0% | 5 qtrs — |
| 47 | TOWER RESEARCH CAPITAL LLC (TRC) | 3.8K +3.8K (+100.0%) | 2.1K +2.1K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD0.53 +0.0% | 27 qtrs — |
| 48 | SBI SECURITIES CO., LTD. | 3.6K +9.0 (+0.3%) | 1.9K -1.2K (-39.3%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD1.03 -48.5% | 5 qtrs — |
| 49 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 1.5K +— (+0.0%) | 801.00 -521.0 (-39.4%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.36 -61.0% | 8 qtrs — |
| 50 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 1.0K +— (+0.0%) | 534.00 -348.0 (-39.5%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.88 -39.8% | 2 qtrs — |
| 51 | WELLS FARGO & COMPANY/MN | 900.00 -147.0 (-14.0%) | 480.00 -443.0 (-48.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.48 -64.2% | 25 qtrs — |
| 52 | ALLWORTH FINANCIAL LP | 842.00 +— (+0.0%) | 450.00 -293.0 (-39.4%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.88 -39.8% | 2 qtrs — |
| 53 | JPMORGAN CHASE & CO | 407.00 -20.3K (-98.0%) | 217.00 -18.0K (-98.8%) | 0.00% -0.016 pp | 0.00% +0.000 pp | USD0.83 -36.1% | 23 qtrs — |
| 54 | BARCLAYS PLC | 406.00 +26.0 (+6.8%) | 217.00 -118.0 (-35.2%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.89 -40.4% | 5 qtrs — |
| 55 | BANK OF AMERICA CORP /DE/ | 178.00 +8.0 (+4.7%) | 95.00 -55.0 (-36.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.71 -69.0% | 24 qtrs — |
| 56 | BNP PARIBAS ARBITRAGE, SNC | 26.00 +— (+0.0%) | 14.00 -9.0 (-39.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.08 -50.9% | 27 qtrs — |
| 57 | SMARTLEAF ASSET MANAGEMENT LLC | 21.00 +21.0 (+100.0%) | 11.00 +11.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.52 +1.9% | 1 qtrs NEW |
| 58 | CALDWELL SUTTER CAPITAL, INC. | 3.00 +— (+0.0%) | 2.00 -1.0 (-33.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.33 -77.3% | 11 qtrs — |
| 59 | PARALLEL ADVISORS, LLC | 2.00 +— (+0.0%) | 1.00 -1.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 -47.0% | 13 qtrs — |
| 60 | BELL INVESTMENT ADVISORS, INC | — -649.0 (-100.0%) | — -573.0 (-100.0%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 61 | SIMPLEX TRADING, LLC | — -4.4K (-100.0%) | — -3.0K (-100.0%) | 0.00% -0.003 pp | 0.00% +0.000 pp | USD— | 8 qtrs SOLD |
| 62 | ROYAL BANK OF CANADA | — -54.4K (-100.0%) | — -48.0K (-100.0%) | 0.00% -0.041 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 63 | EXOME ASSET MANAGEMENT LLC | — -173.9K (-100.0%) | — -153.3K (-100.0%) | 0.00% -0.132 pp | 0.00% -0.093 pp | USD— | 2 qtrs SOLD |
| 64 | RING MOUNTAIN CAPITAL, LLC | — -18.0K (-100.0%) | — -16.0K (-100.0%) | 0.00% -0.014 pp | 0.00% -0.009 pp | USD— | 5 qtrs SOLD |
| 65 | VIRTU FINANCIAL LLC | — -112.3K (-100.0%) | — -99.0K (-100.0%) | 0.00% -0.085 pp | 0.00% -0.006 pp | USD— | 2 qtrs SOLD |
| 66 | ADVISOR GROUP HOLDINGS, INC. | — -2.0K (-100.0%) | — -1.6K (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 67 | RENAISSANCE TECHNOLOGIES LLC | — -391.7K (-100.0%) | — -345.3K (-100.0%) | 0.00% -0.296 pp | 0.00% -0.001 pp | USD— | 15 qtrs SOLD |
| 68 | QUBE RESEARCH & TECHNOLOGIES LTD | — -32.7K (-100.0%) | — -28.8K (-100.0%) | 0.00% -0.025 pp | 0.00% +0.000 pp | USD— | 10 qtrs SOLD |
| 69 | SOLEUS CAPITAL MANAGEMENT, L.P. | — -1.6M (-100.0%) | — -1.4M (-100.0%) | 0.00% -1.195 pp | 0.00% -0.070 pp | USD— | 17 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 16 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Simplify Propel Opportunities ETF SURI | 0.59% | 453.8K | 2.82% |
| 2 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.49% | 108.3K | 0.20% |
| 3 | ALPS Medical Breakthroughs ETF SBIO | 0.10% | 219.7K | 0.50% |
| 4 | iShares Micro-Cap ETF IWC | 0.05% | 683.0K | 0.60% |
| 5 | Avantis U.S. Small Cap Equity ETF AVSC | 0.00% | 91.6K | 0.25% |
| 6 | Vanguard Extended Market ETF VXF | 0.00% | 1.98M | 0.05% |
| 7 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 2.4K | 0.17% |
| 8 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 11.6K | 0.03% |
| 9 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 31.9K | 0.17% |
| 10 | Vanguard Total Stock Market ETF VTI | 0.00% | 5.45M | 0.03% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
10
Sells
0
Shares acquired
6.35M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+6,345,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-24 | Panzara Michael A. | Officer | A-Award | A | Stock Option | 300,000 | 8.80 | 2.64M | 300,000 | D | ↗ |
| 2026-03-27 | Congleton Jon | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-02-17 | Nagel Robert Thorvald | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-02-17 | BVF PARTNERS L P/IL | Director | — | — | Common Stock, $0.0001 par value | 0 | 0.00 | — | 4,135,956 | D | ↗ |
| 2025-07-16 | Whaley Glenn | Officer | A-Award | A | Stock Appreciation Right | 280,000 | 0.77 | 215.6K | 280,000 | D | ↗ |
| 2025-07-16 | Vitt Daniel | Director / Officer | A-Award | A | Stock Appreciation Right | 860,000 | 0.77 | 662.2K | 860,000 | D | ↗ |
| 2025-07-16 | Tardio Jason | Officer | A-Award | A | Stock Appreciation Right | 330,000 | 0.77 | 254.1K | 330,000 | D | ↗ |
| 2025-07-16 | Nash Duane | Director / Officer | A-Award | A | Stock Appreciation Right | 315,000 | 0.77 | 242.6K | 315,000 | D | ↗ |
| 2025-07-16 | Muehler Andreas | Officer | A-Award | A | Stock Appreciation Right | 330,000 | 0.77 | 254.1K | 330,000 | D | ↗ |
| 2025-06-13 | Nash Duane | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 0.83 | 16.7K | 36,032 | D | ↗ |
| 2025-06-05 | Whaley Glenn | Officer | A-Award | A | Stock Option | 503,000 | 0.77 | 388.8K | 503,000 | D | ↗ |
| 2025-06-05 | Vitt Daniel | Director / Officer | A-Award | A | Stock Option | 1,535,000 | 0.77 | 1.19M | 1,535,000 | D | ↗ |
| 2025-06-05 | Toernsen Monika Maria | Director | A-Award | A | Stock Option | 150,000 | 0.77 | 115.9K | 150,000 | D | ↗ |
| 2025-06-05 | Tardio Jason | Officer | A-Award | A | Stock Option | 595,000 | 0.77 | 459.9K | 595,000 | D | ↗ |
| 2025-06-05 | Skerjanec Simona | Director | A-Award | A | Stock Option | 150,000 | 0.77 | 115.9K | 150,000 | D | ↗ |
| 2025-06-05 | Rudick Richard Alan | Director | A-Award | A | Stock Option | 150,000 | 0.77 | 115.9K | 150,000 | D | ↗ |
| 2025-06-05 | PHILLIPS BARCLAY A | Director | A-Award | A | Stock Option | 150,000 | 0.77 | 115.9K | 150,000 | D | ↗ |
| 2025-06-05 | Neermann Joerg | Director | P-Purchase | A | Common Stock | 30,000 | 0.76 | 22.8K | 200,000 | D | ↗ |
| 2025-06-05 | Nash Duane | Director / Officer | A-Award | A | Stock Option | 560,000 | 0.77 | 432.8K | 560,000 | D | ↗ |
| 2025-06-05 | Muehler Andreas | Officer | A-Award | A | Stock Option | 595,000 | 0.77 | 459.9K | 595,000 | D | ↗ |
| 2025-06-05 | HOWSON TAMAR D | Director | A-Award | A | Stock Option | 150,000 | 0.77 | 115.9K | 150,000 | D | ↗ |
| 2025-06-04 | Vitt Daniel | Director / Officer | P-Purchase | A | Common Stock | 15,000 | 0.77 | 11.6K | 29,000 | D | ↗ |
| 2025-06-04 | Neermann Joerg | Director | P-Purchase | A | Common Stock | 70,000 | 0.77 | 53.9K | 170,000 | D | ↗ |
| 2025-06-03 | Whaley Glenn | Officer | P-Purchase | A | Common Stock | 45,000 | 0.71 | 32.1K | 95,510 | D | ↗ |
| 2025-06-03 | Rudick Richard Alan | Director | P-Purchase | A | Common Stock | 143,075 | 0.70 | 100.0K | 230,375 | D | ↗ |
| 2025-05-30 | Whaley Glenn | Officer | A-Award | A | Common Stock | 25,000 | 0.56 | 14.0K | 50,510 | D | ↗ |
| 2024-12-04 | Whaley Glenn | Officer | A-Award | A | Stock Option | 265,000 | 1.25 | 331.3K | 265,000 | D | ↗ |
| 2024-12-04 | Vitt Daniel | Director / Officer | A-Award | A | Stock Option | 820,000 | 1.25 | 1.03M | 820,000 | D | ↗ |
| 2024-12-04 | Tardio Jason | Officer | A-Award | A | Stock Option | 157,500 | 1.25 | 196.9K | 157,500 | D | ↗ |
| 2024-12-04 | Nash Duane | Director / Officer | A-Award | A | Stock Option | 300,000 | 1.25 | 375.0K | 300,000 | D | ↗ |
| 2024-12-04 | Muehler Andreas | Officer | A-Award | A | Stock Option | 315,000 | 1.25 | 393.8K | 315,000 | D | ↗ |
| 2024-11-12 | Rudick Richard Alan | Director | P-Purchase | A | Common Stock | 87,300 | 1.15 | 100.4K | 87,300 | D | ↗ |
| 2024-07-22 | Skerjanec Simona | Director | A-Award | A | Stock Option | 100,000 | 1.46 | 146.0K | 100,000 | — | ↗ |
| 2024-07-12 | Tardio Jason | Officer | A-Award | A | Stock Option | 500,000 | 1.25 | 625.0K | 500,000 | — | ↗ |
| 2024-06-11 | Toernsen Monika Maria | Director | A-Award | A | Stock Option | 100,000 | 1.27 | 127.0K | 100,000 | — | ↗ |
| 2024-06-11 | Rudick Richard Alan | Director | A-Award | A | Stock Option | 100,000 | 1.27 | 127.0K | 100,000 | — | ↗ |
| 2024-06-11 | PHILLIPS BARCLAY A | Director | A-Award | A | Stock Option | 100,000 | 1.27 | 127.0K | 100,000 | — | ↗ |
| 2024-06-11 | Neermann Joerg | Director | A-Award | A | Stock Option | 100,000 | 1.27 | 127.0K | 100,000 | — | ↗ |
| 2024-06-11 | HOWSON TAMAR D | Director | A-Award | A | Stock Option | 100,000 | 1.27 | 127.0K | 100,000 | — | ↗ |
| 2024-03-04 | Whaley Glenn | Officer | D-Return | D | Stock Option | 40,000 | 10.88 | 435.2K | 0 | — | ↗ |
| 2024-03-04 | Vitt Daniel | Director / Officer | D-Return | D | Stock Option | 65,000 | 13.29 | 863.9K | 0 | — | ↗ |
| 2024-03-04 | Toernsen Monika Maria | Director | A-Award | A | Stock Option | 30,000 | 1.72 | 51.6K | 30,000 | — | ↗ |
| 2024-03-04 | PHILLIPS BARCLAY A | Director | D-Return | D | Stock Option | 9,986 | 7.63 | 76.2K | 0 | — | ↗ |
| 2024-03-04 | Neermann Joerg | Director | A-Award | A | Stock Option | 64,959 | 1.72 | 111.7K | 64,959 | — | ↗ |
| 2024-03-04 | Nash Duane | Director / Officer | D-Return | D | Stock Option | 10,000 | 3.40 | 34.0K | 0 | — | ↗ |
| 2024-03-04 | Muehler Andreas | Officer | D-Return | D | Stock Option | 30,000 | 13.29 | 398.7K | 0 | — | ↗ |
| 2024-03-04 | HOWSON TAMAR D | Director | A-Award | A | Stock Option | 64,959 | 1.72 | 111.7K | 64,959 | — | ↗ |
| 2024-02-26 | Vitt Daniel | Director / Officer | P-Purchase | A | Common Stock | 14,000 | 1.31 | 18.3K | 390,877 | — | ↗ |
| 2024-01-17 | Whaley Glenn | Officer | A-Award | A | Stock Option | 295,400 | 1.21 | 357.4K | 295,400 | — | ↗ |
| 2024-01-17 | Vitt Daniel | Director / Officer | A-Award | A | Stock Option | 1,160,000 | 1.21 | 1.40M | 1,160,000 | — | ↗ |
| 2024-01-17 | Nash Duane | Director / Officer | A-Award | A | Stock Option | 300,000 | 1.21 | 363.0K | 300,000 | — | ↗ |
| 2024-01-17 | Muehler Andreas | Officer | A-Award | A | Stock Option | 335,400 | 1.21 | 405.8K | 335,400 | — | ↗ |
| 2023-06-28 | Toernsen Monika Maria | Director | A-Award | A | Stock Option | 16,000 | 1.94 | 31.0K | 16,000 | — | ↗ |
| 2023-06-28 | Rudick Richard Alan | Director | A-Award | A | Stock Option | 16,000 | 1.94 | 31.0K | 16,000 | — | ↗ |
| 2023-06-28 | PHILLIPS BARCLAY A | Director | A-Award | A | Stock Option | 16,000 | 1.94 | 31.0K | 16,000 | — | ↗ |
| 2023-06-28 | Neermann Joerg | Director | A-Award | A | Stock Option | 16,000 | 1.94 | 31.0K | 16,000 | — | ↗ |
| 2023-06-28 | HOWSON TAMAR D | Director | A-Award | A | Stock Option | 16,000 | 1.94 | 31.0K | 16,000 | — | ↗ |
| 2023-05-15 | Whaley Glenn | Officer | P-Purchase | A | Common Stock | 5,000 | 1.75 | 8.8K | 25,510 | — | ↗ |
| 2023-04-26 | Rudick Richard Alan | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-01-02 | Whaley Glenn | Officer | A-Award | A | Stock Option | 110,000 | 0.00 | — | 110,000 | — | ↗ |
| 2023-01-02 | Vitt Daniel | Officer | A-Award | A | Stock Option | 300,000 | 0.00 | — | 300,000 | — | ↗ |
| 2023-01-02 | Nash Duane | Officer | A-Award | A | Stock Option | 132,000 | 0.00 | — | 132,000 | — | ↗ |
| 2023-01-02 | Muehler Andreas | Officer | A-Award | A | Stock Option | 132,000 | 0.00 | — | 132,000 | — | ↗ |
| 2022-12-14 | Neermann Joerg | Director | P-Purchase | A | Common Stock | 47,000 | 1.26 | 59.0K | 100,000 | — | ↗ |
| 2022-12-13 | Neermann Joerg | Director | P-Purchase | A | Common Stock | 35,000 | 1.25 | 43.6K | 53,000 | — | ↗ |
| 2022-11-23 | Neermann Joerg | Director | P-Purchase | A | Common Stock | 18,000 | 1.39 | 25.0K | 18,000 | — | ↗ |
| 2022-11-22 | Vitt Daniel | Officer | P-Purchase | A | Common Stock | 8,000 | 1.35 | 10.8K | 376,877 | — | ↗ |
| 2022-11-07 | Whaley Glenn | Officer | P-Purchase | A | Common Stock | 5,000 | 1.50 | 7.5K | 20,510 | — | ↗ |
| 2022-07-08 | Toernsen Monika Maria | Director | A-Award | A | Stock Option | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2022-07-05 | Toernsen Monika Maria | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-06-15 | van den Bossche Jan | Director | A-Award | A | Stock Option | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-06-15 | Whaley Glenn | Officer | A-Award | A | Stock Option | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-06-15 | Vitt Daniel | Officer | A-Award | A | Stock Option | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-06-15 | PHILLIPS BARCLAY A | Director | A-Award | A | Stock Option | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-06-15 | Ossipow Vincent | Director | A-Award | A | Stock Option | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-06-15 | Neermann Joerg | Director | A-Award | A | Stock Option | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-06-15 | Nash Duane | Director / Officer | A-Award | A | Stock Option | 10,000 | 3.40 | 34.0K | 10,000 | — | ↗ |
| 2022-06-15 | Muehler Andreas | Officer | A-Award | A | Stock Option | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-06-15 | HOWSON TAMAR D | Director | A-Award | A | Stock Option | 10,000 | 3.40 | 34.0K | 10,000 | — | ↗ |
| 2022-06-03 | Whaley Glenn | Officer | P-Purchase | A | Common Stock | 3,500 | 3.05 | 10.7K | 12,568 | — | ↗ |
| 2022-06-03 | Vitt Daniel | Officer | P-Purchase | A | Common Stock | 5,000 | 3.10 | 15.5K | 368,877 | — | ↗ |
| 2022-05-12 | Whaley Glenn | Officer | P-Purchase | A | Common Stock | 3,000 | 5.08 | 15.2K | 9,068 | — | ↗ |
| 2022-05-12 | Nash Duane | Officer | P-Purchase | A | Common Stock | 10,000 | 5.03 | 50.3K | 22,032 | — | ↗ |
| 2022-05-12 | Muehler Andreas | Officer | P-Purchase | A | Common Stock | 3,500 | 5.10 | 17.9K | 297,986 | — | ↗ |
| 2022-03-10 | Whaley Glenn | Officer | A-Award | A | Stock Option | 40,000 | 10.88 | 435.2K | 40,000 | — | ↗ |
| 2022-03-10 | Nash Duane | Director / Officer | A-Award | A | Stock Option | 75,000 | 10.88 | 816.0K | 75,000 | — | ↗ |
| 2022-01-03 | Whaley Glenn | Officer | A-Award | A | Stock Option | 70,000 | 10.73 | 751.1K | 70,000 | — | ↗ |
| 2022-01-03 | Vitt Daniel | Director / Officer | A-Award | A | Stock Option | 215,000 | 10.73 | 2.31M | 215,000 | — | ↗ |
| 2022-01-03 | Muehler Andreas | Officer | A-Award | A | Stock Option | 100,000 | 10.73 | 1.07M | 100,000 | — | ↗ |
| 2021-12-31 | Nash Duane | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-08-10 | Whaley Glenn | Officer | P-Purchase | A | Common Stock | 1,500 | 9.85 | 14.8K | 3,500 | — | ↗ |
| 2021-08-10 | Vitt Daniel | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 9.60 | 9.6K | 363,877 | — | ↗ |
| 2021-08-10 | Nash Duane | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 9.80 | 9.8K | 15,032 | — | ↗ |
| 2021-06-10 | van den Bossche Jan | Director | A-Award | A | Stock Option | 10,000 | 14.77 | 147.7K | 10,000 | — | ↗ |
| 2021-06-10 | PHILLIPS BARCLAY A | Director | A-Award | A | Stock Option | 10,000 | 14.77 | 147.7K | 10,000 | — | ↗ |
| 2021-06-10 | Ossipow Vincent | Director | A-Award | A | Stock Option | 25,000 | 14.77 | 369.3K | 25,000 | — | ↗ |
| 2021-06-10 | Neermann Joerg | Director | A-Award | A | Stock Option | 10,000 | 14.77 | 147.7K | 10,000 | — | ↗ |
| 2021-06-10 | Nash Duane | Director / Officer | A-Award | A | Stock Option | 10,000 | 14.77 | 147.7K | 10,000 | — | ↗ |
| 2021-06-10 | HOWSON TAMAR D | Director | A-Award | A | Stock Option | 10,000 | 14.77 | 147.7K | 10,000 | — | ↗ |
| 2021-05-12 | Nash Duane | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 12.75 | 51.0K | 14,032 | — | ↗ |
| 2021-04-15 | Nash Duane | Director / Officer | A-Award | A | Stock Option | 90,000 | 15.44 | 1.39M | 90,000 | — | ↗ |
| 2021-03-10 | Muehler Andreas | Officer | — | D | Stock Option | 30,000 | 13.29 | 398.7K | 0 | — | ↗ |
| 2021-03-02 | Whaley Glenn | Officer | P-Purchase | A | Common Stock | 1,000 | 16.48 | 16.5K | 2,000 | — | ↗ |
| 2021-03-02 | Muehler Andreas | Officer | P-Purchase | A | Common Stock | 10,006 | 15.54 | 155.5K | 294,486 | — | ↗ |
| 2021-03-01 | Whaley Glenn | Officer | A-Award | A | Stock Option | 40,000 | 15.72 | 628.8K | 40,000 | — | ↗ |
| 2021-03-01 | Vitt Daniel | Director / Officer | A-Award | A | Stock Option | 115,000 | 15.72 | 1.81M | 115,000 | — | ↗ |
| 2021-03-01 | Groeppel Manfred | Officer | A-Award | A | Stock Option | 45,000 | 15.72 | 707.4K | 45,000 | — | ↗ |
| 2020-10-22 | Nash Duane | Director / Officer | A-Award | A | Stock Option | 120,000 | 17.00 | 2.04M | 120,000 | — | ↗ |
| 2020-08-10 | Whaley Glenn | Officer | P-Purchase | A | Common Stock | 1,000 | 18.96 | 19.0K | 1,000 | — | ↗ |
| 2020-07-21 | Vitt Daniel | Director / Officer | S-Sale | D | Common Stock | 1,300 | 15.62 | 20.3K | 362,877 | — | ↗ |
| 2020-07-21 | Groeppel Manfred | Officer | S-Sale | D | Common Stock | 650 | 15.62 | 10.2K | 278,830 | — | ↗ |
| 2020-07-20 | Vitt Daniel | Director / Officer | S-Sale | D | Common Stock | 5,000 | 14.44 | 72.2K | 364,177 | — | ↗ |
| 2020-07-20 | Groeppel Manfred | Officer | S-Sale | D | Common Stock | 5,000 | 14.44 | 72.2K | 279,480 | — | ↗ |
| 2020-07-02 | van den Bossche Jan | Director | A-Award | A | Stock Option | 15,000 | 12.30 | 184.5K | 15,000 | — | ↗ |
| 2020-07-02 | Whaley Glenn | Officer | A-Award | A | Stock Option | 30,000 | 12.30 | 369.0K | 30,000 | — | ↗ |
| 2020-07-02 | Vitt Daniel | Director / Officer | A-Award | A | Stock Option | 80,000 | 12.30 | 984.0K | 80,000 | — | ↗ |
| 2020-07-02 | PHILLIPS BARCLAY A | Director | A-Award | A | Stock Option | 15,000 | 12.30 | 184.5K | 15,000 | — | ↗ |
| 2020-07-02 | Neermann Joerg | Director | A-Award | A | Stock Option | 15,000 | 12.30 | 184.5K | 15,000 | — | ↗ |
| 2020-07-02 | Nash Duane | Director | A-Award | A | Stock Option | 45,000 | 12.30 | 553.5K | 45,000 | — | ↗ |
| 2020-07-02 | HOWSON TAMAR D | Director | A-Award | A | Stock Option | 15,000 | 12.30 | 184.5K | 15,000 | — | ↗ |
| 2020-07-02 | Groeppel Manfred | Officer | A-Award | A | Stock Option | 30,000 | 12.30 | 369.0K | 30,000 | — | ↗ |
| 2020-04-29 | Whaley Glenn | Officer | A-Award | A | Stock Option | 15,000 | 8.84 | 132.6K | 15,000 | — | ↗ |
| 2019-12-04 | Nash Duane | Director | S-Sale | D | Common Stock | 4,400 | 6.96 | 30.6K | 10,032 | — | ↗ |
| 2019-12-03 | Nash Duane | Director | F-InKind | D | Common Stock | 7,930 | 7.15 | 56.7K | 14,432 | — | ↗ |
| 2019-12-02 | Nash Duane | Director | M-Exempt | A | Common Stock | 22,157 | 0.00 | — | 22,362 | — | ↗ |
| 2019-12-01 | Whaley Glenn | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-11-18 | PHILLIPS BARCLAY A | Director | A-Award | A | Stock Option | 29,959 | 7.63 | 228.6K | 29,959 | — | ↗ |
| 2019-10-11 | HOWSON TAMAR D | Director | A-Award | A | Stock Option | 29,959 | 9.54 | 285.8K | 29,959 | — | ↗ |
| 2019-08-01 | Vitt Daniel | Director / Officer | A-Award | A | Stock Option | 65,000 | 13.29 | 863.9K | 65,000 | — | ↗ |
| 2019-08-01 | Groeppel Manfred | Officer | A-Award | A | Stock Option | 20,000 | 13.29 | 265.8K | 20,000 | — | ↗ |
| 2019-07-22 | van den Bossche Jan | Director | A-Award | A | Stock Option | 29,959 | 13.63 | 408.3K | 29,959 | — | ↗ |
| 2019-07-22 | Patel Sanjay S | Officer | A-Award | A | Stock Option | 79,891 | 13.63 | 1.09M | 79,891 | — | ↗ |
| 2019-07-22 | Ossipow Vincent | Director | A-Award | A | Stock Option | 29,959 | 13.63 | 408.3K | 29,959 | — | ↗ |
| 2019-07-22 | Neermann Joerg | Director | A-Award | A | Stock Option | 29,959 | 13.63 | 408.3K | 29,959 | — | ↗ |
| 2019-07-22 | Nash Duane | Director | A-Award | A | Stock Option | 29,959 | 13.63 | 408.3K | 29,959 | — | ↗ |
| 2019-07-15 | Patel Sanjay S | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-04-12 | van den Bossche Jan | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-04-12 | Vitt Daniel | Director / Officer | — | I | Common Stock | 0 | 0.00 | — | 369,177 | — | ↗ |
| 2019-04-12 | Ossipow Vincent | Director | — | I | Common Stock | 0 | 0.00 | — | 1,371,494 | — | ↗ |
| 2019-04-12 | Neermann Joerg | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-04-12 | LSP V Cooperatieve U.A. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 2,162,782 | — | ↗ |
| 2019-04-12 | Groeppel Manfred | Officer | — | I | Common Stock | 0 | 0.00 | — | 284,480 | — | ↗ |
| 2019-04-12 | Global Life Bioventure V Sarl | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,371,494 | — | ↗ |
| 2019-04-12 | Fund N.V. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,371,494 | — | ↗ |
| 2019-01-11 | Swanson Michael V. | Officer | A-Award | A | Restricted Stock Units | 817,826 | 0.00 | — | 817,826 | — | ↗ |
| 2019-01-11 | Nash Duane | Officer | A-Award | A | Restricted Stock Units | 886,316 | 0.00 | — | 886,316 | — | ↗ |
| 2019-01-11 | DUNN JOHN MICHAEL | Officer | A-Award | A | Restricted Stock Units | 724,848 | 0.00 | — | 724,848 | — | ↗ |
| 2019-01-11 | Cox Russell J. | Director / Officer | D-Return | D | Stock Option (right to buy) | 1,588,832 | 6.30 | 10.01M | 0 | — | ↗ |
| 2019-01-11 | Ashley Robert A. | Officer | D-Return | D | Stock Option (right to buy) | 75,000 | 8.28 | 621.0K | 0 | — | ↗ |
| 2018-09-25 | Halperin Errol R. | Director | S-Sale | D | Common Stock | 10,000 | 0.29 | 2.9K | 0 | — | ↗ |
| 2018-09-24 | BIENAIME JEAN JACQUES | Director | S-Sale | D | Common Stock | 26,619 | 0.30 | 8.0K | 18,500 | — | ↗ |
| 2018-09-19 | Godshall Douglas Evan | Director | S-Sale | D | Common Stock | 69,375 | 0.35 | 24.2K | 0 | — | ↗ |
| 2018-09-17 | Satter Muneer A | Director / 10% Owner | S-Sale | D | Common Stock | 7,044,777 | 0.29 | 2.05M | 0 | — | ↗ |
| 2018-09-14 | Satter Muneer A | Director / 10% Owner | S-Sale | D | Common Stock | 447,500 | 0.36 | 160.4K | 7,044,777 | — | ↗ |
| 2018-09-13 | Satter Muneer A | Director / 10% Owner | S-Sale | D | Common Stock | 3,890,000 | 0.50 | 1.93M | 7,492,277 | — | ↗ |
| 2018-09-13 | Hasnain Faheem | Director | S-Sale | D | Common Stock | 59,200 | 0.44 | 25.9K | 122,743 | — | ↗ |
| 2018-09-13 | BIENAIME JEAN JACQUES | Director | S-Sale | D | Common Stock | 20,000 | 0.47 | 9.4K | 45,119 | — | ↗ |
| 2018-09-12 | Cohen Cheryl | Director | S-Sale | D | Common Stock | 3,500 | 0.55 | 1.9K | 0 | — | ↗ |
| 2018-07-01 | Stern Aron | Officer | A-Award | A | Stock Option (right to buy) | 20,000 | 6.85 | 137.0K | 20,000 | — | ↗ |
| 2018-06-09 | Swanson Michael V. | Officer | A-Award | A | Stock Option (right to buy) | 75,000 | 5.00 | 375.0K | 75,000 | — | ↗ |
| 2018-06-09 | Nash Duane | Officer | A-Award | A | Stock Option (right to buy) | 85,000 | 5.00 | 425.0K | 85,000 | — | ↗ |
| 2018-06-09 | MURAWSKI RICHARD M | Officer | A-Award | A | Stock Option (right to buy) | 45,000 | 5.00 | 225.0K | 45,000 | — | ↗ |
| 2018-06-09 | Henry Andrew | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 5.00 | 250.0K | 50,000 | — | ↗ |
| 2018-06-09 | DUNN JOHN MICHAEL | Officer | A-Award | A | Stock Option (right to buy) | 45,000 | 5.00 | 225.0K | 45,000 | — | ↗ |
| 2018-06-09 | Ashley Robert A. | Officer | A-Award | A | Stock Option (right to buy) | 75,000 | 5.00 | 375.0K | 75,000 | — | ↗ |
| 2018-05-23 | Satter Muneer A | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 29,538 | 6.10 | 180.2K | 29,538 | — | ↗ |
| 2018-05-23 | SEARS LOWELL | Director | A-Award | A | Stock Option (right to buy) | 29,538 | 6.10 | 180.2K | 29,538 | — | ↗ |
| 2018-05-23 | Millis J. Michael | Director | A-Award | A | Stock Option (right to buy) | 29,538 | 6.10 | 180.2K | 29,538 | — | ↗ |
| 2018-05-23 | Hasnain Faheem | Director | A-Award | A | Stock Option (right to buy) | 41,353 | 6.10 | 252.3K | 41,353 | — | ↗ |
| 2018-05-23 | Halperin Errol R. | Director | A-Award | A | Stock Option (right to buy) | 29,538 | 6.10 | 180.2K | 29,538 | — | ↗ |
| 2018-05-23 | Godshall Douglas Evan | Director | A-Award | A | Stock Option (right to buy) | 29,538 | 6.10 | 180.2K | 29,538 | — | ↗ |
| 2018-05-23 | Cohen Cheryl | Director | A-Award | A | Stock Option (right to buy) | 29,538 | 6.10 | 180.2K | 29,538 | — | ↗ |
| 2018-05-23 | BIENAIME JEAN JACQUES | Director | A-Award | A | Stock Option (right to buy) | 29,538 | 6.10 | 180.2K | 29,538 | — | ↗ |
| 2018-01-03 | Cox Russell J. | Director / Officer | A-Award | A | Non-Qualifed Stock Option (right to buy) | 1,588,832 | 6.30 | 10.01M | 1,588,832 | — | ↗ |
| 2017-12-13 | Satter Muneer A | Director / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 5.57 | 278.6K | 11,382,277 | — | ↗ |
| 2017-12-12 | Satter Muneer A | Director / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 5.40 | 269.8K | 11,332,277 | — | ↗ |
| 2017-12-11 | Satter Muneer A | Director / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 4.96 | 248.2K | 11,282,277 | — | ↗ |
| 2017-12-08 | Satter Muneer A | Director / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 4.92 | 246.2K | 11,232,277 | — | ↗ |
| 2017-12-07 | Satter Muneer A | Director / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 4.77 | 238.7K | 11,182,277 | — | ↗ |
| 2017-09-14 | Satter Muneer A | Director / 10% Owner | P-Purchase | A | Common Stock | 30,000 | 4.25 | 127.5K | 11,132,277 | — | ↗ |
| 2017-09-14 | Hasnain Faheem | Director | P-Purchase | A | Common Stock | 59,200 | 4.19 | 247.9K | 181,943 | — | ↗ |
| 2017-09-13 | Satter Muneer A | Director / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 4.13 | 206.5K | 11,102,277 | — | ↗ |
| 2017-09-13 | BIENAIME JEAN JACQUES | Director | P-Purchase | A | Common Stock | 10,000 | 4.00 | 40.0K | 65,119 | — | ↗ |
| 2017-09-12 | Satter Muneer A | Director / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 3.74 | 187.2K | 11,052,277 | — | ↗ |
| 2017-09-08 | Satter Muneer A | Director / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 3.53 | 176.6K | 11,002,277 | — | ↗ |
| 2017-09-05 | Hasnain Faheem | Director | A-Award | A | Stock Option (right to buy) | 15,222 | 3.15 | 47.9K | 15,222 | — | ↗ |
| 2017-06-14 | Winters Terence E. | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 3.10 | 31.0K | 194,966 | — | ↗ |
| 2017-06-14 | Satter Muneer A | Director / 10% Owner | P-Purchase | A | Common Stock | 10,000 | 3.10 | 31.0K | 10,952,277 | — | ↗ |
| 2017-06-14 | DUNN JOHN MICHAEL | Officer | P-Purchase | A | Common Stock | 2,400 | 3.09 | 7.4K | 11,885 | — | ↗ |
| 2017-06-13 | Satter Muneer A | Director / 10% Owner | P-Purchase | A | Common Stock | 10,000 | 3.03 | 30.3K | 10,942,277 | — | ↗ |
| 2017-06-13 | BIENAIME JEAN JACQUES | Director | P-Purchase | A | Common Stock | 16,000 | 3.00 | 48.1K | 55,119 | — | ↗ |
| 2017-06-12 | Satter Muneer A | Director / 10% Owner | P-Purchase | A | Common Stock | 10,000 | 3.06 | 30.6K | 10,932,277 | — | ↗ |
| 2017-06-10 | Winters Terence E. | Director / Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 3.20 | 320.0K | 100,000 | — | ↗ |
| 2017-06-10 | Swanson Michael V. | Officer | A-Award | A | Stock Option (right to buy) | 75,000 | 3.20 | 240.0K | 75,000 | — | ↗ |
| 2017-06-10 | Stern Aron | Officer | A-Award | A | Stock Option (right to buy) | 22,143 | 3.20 | 70.9K | 22,143 | — | ↗ |
| 2017-06-10 | Nash Duane | Officer | A-Award | A | Stock Option (right to buy) | 85,000 | 3.20 | 272.0K | 85,000 | — | ↗ |
| 2017-06-10 | MURAWSKI RICHARD M | Officer | A-Award | A | Stock Option (right to buy) | 45,000 | 3.20 | 144.0K | 45,000 | — | ↗ |
| 2017-06-10 | Henry Andrew | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 3.20 | 160.0K | 50,000 | — | ↗ |
| 2017-06-10 | DUNN JOHN MICHAEL | Officer | A-Award | A | Stock Option (right to buy) | 45,000 | 3.20 | 144.0K | 45,000 | — | ↗ |
| 2017-06-10 | Ashley Robert A. | Officer | A-Award | A | Stock Option (right to buy) | 75,000 | 3.20 | 240.0K | 75,000 | — | ↗ |
Executive team
Top executives
Shares Outstanding
9.87M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Dr. Daniel Vitt Chief Executive Officer | 610.0K | — | — | 2.16M | 167.7K | — | 2.94M | 73.53% | ↗ |
| 2 | 2024 | Dr. Andreas Muehler Chief Medical Officer | 500.0K | — | — | 752.1K | 100.0K | 16.1K | 1.37M | 54.97% | ↗ |
| 3 | 2024 | Dr. Duane D. Nash Executive Chairman | 388.4K | — | — | 745.7K | 77.7K | — | 1.21M | 61.54% | ↗ |
| 4 | 2024 | Glenn Whaley Chief Financial Officer | 445.0K | — | — | 638.0K | 89.0K | — | 1.17M | 54.44% | ↗ |
| 5 | 2024 | Jason Tardio COO and President | 250.0K | — | — | 670.2K | 110.0K | — | 1.03M | 65.06% | ↗ |
| 6 | 2023 | Dr. Daniel Vitt Chief Executive Officer | 585.0K | — | — | 341.9K | 284.9K | — | 1.21M | 28.21% | ↗ |
| 7 | 2023 | Dr. Daniel Vitt Chief Executive Officer, President | 585.0K | — | — | 341.9K | 284.9K | — | 1.21M | 28.21% | ↗ |
| 8 | 2023 | Dr. Andreas Muehler Chief Medical Officer | 493.0K | — | — | 150.4K | 185.7K | 16.1K | 845.3K | 17.80% | ↗ |
| 9 | 2023 | Glenn Whaley Chief Financial Officer | 415.0K | — | — | 125.4K | 161.9K | — | 702.2K | 17.85% | ↗ |
| 10 | 2023 | Dr. Duane Nash Executive Chairman | 363.0K | — | — | 144.4K | 141.6K | — | 648.9K | 22.25% | ↗ |
| 11 | 2023 | Dr. Duane D. Nash Executive Chairman | 363.0K | — | — | 144.4K | 141.6K | — | 648.9K | 22.25% | ↗ |
| 12 | 2022 | Dr. Daniel Vitt Chief Executive Officer, President | 519.6K | — | — | 1.83M | 208.8K | — | 2.56M | 71.52% | ↗ |
| 13 | 2022 | Glenn Whaley Chief Financial Officer | 401.7K | — | — | 953.8K | 120.5K | — | 1.48M | 64.62% | ↗ |
| 14 | 2022 | Dr. Andreas Muehler Chief Medical Officer | 445.9K | — | — | 865.2K | 137.9K | 15.8K | 1.46M | 59.07% | ↗ |
| 15 | 2022 | Dr. Duane Nash Executive Chairman | 347.4K | — | — | 635.2K | 86.0K | — | 1.07M | 59.44% | ↗ |
| 16 | 2021 | Dr. Daniel Vitt Chief Executive Officer, President | 399.2K | — | — | 1.38M | 157.2K | — | 1.94M | 71.26% | ↗ |
| 17 | 2021 | Dr. Duane Nash Executive Chairman | 326.6K | — | — | 980.5K | 100.0K | — | 1.41M | 69.68% | ↗ |
| 18 | 2021 | Dr. Andreas Muehler Chief Medical Officer | 378.5K | — | — | 779.8K | 115.9K | 17.6K | 1.29M | 60.36% | ↗ |
| 19 | 2021 | Glenn Whaley Chief Financial Officer | 343.3K | — | — | 479.9K | 105.1K | — | 928.3K | 51.69% | ↗ |
| 20 | 2020 | Dr. Duane Nash Executive Chairman | 214.9K | — | — | 1.84M | 131.5K | 16.3K | 2.20M | 83.51% | ↗ |
| 21 | 2020 | Dr. Daniel Vitt Chief Executive Officer, President | 380.9K | — | — | 708.6K | 228.5K | — | 1.32M | 53.76% | ↗ |
| 22 | 2020 | Dr. Andreas Muehler Chief Medical Officer | 358.2K | — | — | 389.7K | 169.0K | 17.8K | 934.7K | 41.69% | ↗ |
| 23 | 2020 | Glenn Whaley Chief Financial Officer | 310.8K | — | — | 360.1K | 177.3K | — | 848.3K | 42.45% | ↗ |
| 24 | 2020 | Glenn Whaley Principal Financial and Accounting Officer | 310.8K | — | — | 360.1K | 177.3K | — | 848.3K | 42.45% | ↗ |
| 25 | 2019 | Dr. Daniel Vitt Chief Executive Officer, President | 202.3K | — | 1.50M | 573.8K | 112.0K | — | 2.38M | 86.82% | ↗ |
| 26 | 2019 | Dr. Andreas Muehler Chief Medical Officer | 177.8K | — | 1.50M | 353.1K | 79.4K | 11.9K | 2.12M | 87.30% | ↗ |
| 27 | 2019 | Dr. Manfred Gröppel Chief Operating Officer | 137.6K | — | 1.50M | 176.6K | 56.0K | — | 1.87M | 89.62% | ↗ |
| 28 | 2019 | Russell J. Cox Former Chief Executive Officer | 5.7K | — | 468.0K | — | 202.1K | 540.0K | 1.22M | 38.49% | ↗ |
| 29 | 2019 | Duane D. Nash, M.D., J.D. Former Chief Executive Officer | 121.0K | — | 223.7K | 264.8K | 165.9K | 188.8K | 964.2K | 50.66% | ↗ |
| 30 | 2019 | Dr. Duane Nash Executive Chairman | 43.9K | — | — | 264.8K | — | — | 308.7K | 85.79% | ↗ |
| 31 | 2019 | Glenn Whaley Principal Financial and Accounting Officer | 24.6K | — | — | 74.1K | — | — | 98.7K | 75.09% | ↗ |
| 32 | 2018 | Russell J. Cox Former Chief Executive Officer | 572.6K | — | — | 7.08M | 330.0K | 73.4K | 8.06M | 87.89% | ↗ |
| 33 | 2018 | Duane D. Nash, M.D., J.D. Former Chief Executive Officer | 414.8K | — | — | 294.7K | — | 43.6K | 753.2K | 39.13% | ↗ |
| 34 | 2018 | Duane D. Nash, M.D., J.D. Former Chief Executive Officer and President | 414.8K | — | — | 294.7K | — | 43.6K | 753.2K | 39.13% | ↗ |
| 35 | 2018 | Robert A. Ashley, M.A. Former Executive Vice President and Chief Scientific Officer | 396.3K | — | — | 260.1K | — | 47.8K | 704.2K | 36.93% | ↗ |
| 36 | 2017 | Terence E. Winters, Ph.D. Chief Executive Officer | 504.7K | — | — | 902.2K | 219.7K | 550.6K | 2.18M | 41.44% | ↗ |
| 37 | 2017 | Duane D. Nash, M.D., J.D. Former Chief Executive Officer and President | 400.0K | — | — | 193.6K | 177.5K | — | 771.1K | 25.11% | ↗ |
| 38 | 2017 | Duane D. Nash, M.D., J.D. President | 400.0K | — | — | 193.6K | 177.5K | — | 771.1K | 25.11% | ↗ |
| 39 | 2017 | Robert A. Ashley Executive Vice President and Chief Technical Officer | 381.1K | — | — | 170.9K | 158.2K | — | 710.2K | 24.06% | ↗ |
| 40 | 2017 | Robert A. Ashley, M.A. Former Executive Vice President and Chief Scientific Officer | 381.0K | — | — | 170.9K | 158.2K | — | 710.1K | 24.06% | ↗ |
| 41 | 2016 | Terence E. Winters, Ph.D. Co-Chairman and Chief Executive Officer | 490.0K | — | — | 586.4K | 73.5K | 18.8K | 1.17M | 50.18% | ↗ |
| 42 | 2016 | Terence E. Winters, Ph.D. Chief Executive Officer | 490.0K | — | — | 586.4K | 73.5K | 18.8K | 1.17M | 50.18% | ↗ |
| 43 | 2016 | Duane D. Nash, M.D., J.D. President | 375.6K | — | — | 498.4K | 67.8K | — | 941.8K | 52.92% | ↗ |
| 44 | 2016 | Robert A. Ashley Executive Vice President and Chief Technical Officer | 370.0K | — | — | 439.8K | 83.5K | — | 893.3K | 49.23% | ↗ |
| 45 | 2015 | Terence E. Winters, Ph.D. Co-Chairman and Chief Executive Officer | 469.9K | — | — | 296.6K | 100.0K | 17.4K | 883.9K | 33.55% | ↗ |
| 46 | 2015 | Robert A. Ashley Executive Vice President and Chief Technical Officer | 358.0K | — | — | 222.4K | 78.0K | — | 658.4K | 33.78% | ↗ |
| 47 | 2015 | Duane D. Nash, M.D., J.D. President | 358.0K | — | — | 222.4K | 78.0K | — | 658.4K | 33.78% | ↗ |
| 48 | 2015 | Duane D. Nash, M.D. President | 358.0K | — | — | 222.4K | 78.0K | — | 658.4K | 33.78% | ↗ |
| 49 | 2014 | John M. Dunn, J.D. | 35.6K | — | — | 665.1K | — | — | 700.7K | 94.92% | ↗ |
| 50 | 2014 | Terence E. Winters, Ph.D. Co-Chairman and Chief Executive Officer | 450.0K | — | — | — | 171.9K | 16.0K | 637.9K | 0.00% | ↗ |
| 51 | 2014 | Terence E. Winters, Ph.D. Co-Chairman and Chief Executive Officer | 450.0K | — | — | — | 171.9K | 16.0K | 637.9K | 0.00% | ↗ |
| 52 | 2014 | Duane D. Nash, M.D., J.D. President | 350.0K | — | — | — | 100.0K | — | 450.0K | 0.00% | ↗ |
| 53 | 2014 | Duane D. Nash, M.D. President | 350.0K | — | — | — | 100.0K | — | 450.0K | 0.00% | ↗ |
| 54 | 2013 | Terence E. Winters, Ph.D. Co-Chairman and Chief Executive Officer | 418.1K | — | — | — | 110.7K | 16.1K | 544.9K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Daniel Vitt | Chief Executive Officer & Director | 1M | — |
| Andreas Muehler | Chief Medical Officer | 809.8K | — |
| Michael A. Panzara | Chief Medical Officer | 809.8K | — |
| Jason Tardio | Chief Operating Officer & President | 751.7K | male |
| Glenn Whaley | Chief Financial Officer | 682.3K | male |
| Inderpal Singh | General Counsel | — | male |
| Hella Kohlhof | Chief Scientific Officer | — | — |
| Jessica Breu | Head of Investor Relations & Communications | — | female |
| Patrick Walsh | Chief Business Officer | — | male |
| Werner Gladdines | Chief Development Officer | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IMUX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
